The cardiovascular action of hexarelin

Area of Science:

• Cardiovascular Science
• Endocrinology
• Pharmacology

Background:

• Hexarelin is a synthetic peptide that activates the growth hormone secretagogue receptor (GHSR).
• GHSR is found in the brain, heart, and blood vessels, suggesting potential cardiovascular roles for hexarelin.
• Hexarelin also interacts with the non-GHSR receptor CD36, mediating cardioprotective effects.

Purpose of the Study:

• To review the current evidence on the cardiovascular actions of hexarelin.
• To explore hexarelin's potential as a therapeutic agent for cardiovascular diseases.

Main Methods:

• Review of existing scientific literature on hexarelin's biological activity.
• Analysis of studies investigating hexarelin's interaction with GHSR and CD36 receptors.
• Comparison of hexarelin's properties with its natural analog, ghrelin.

Main Results:

• Hexarelin exhibits direct cardiovascular effects independent of growth hormone release.
• The non-GHSR receptor CD36 is identified as a key mediator of hexarelin's cardioprotective actions.
• Hexarelin demonstrates superior chemical stability and functional potency compared to ghrelin.

Conclusions:

• Hexarelin possesses significant cardiovascular actions mediated by both GHSR and CD36.
• Its enhanced stability and potency make hexarelin a promising candidate for treating cardiovascular conditions.
• Further research is warranted to fully elucidate hexarelin's therapeutic potential in cardiology.